|
|
Article: FDA Panel Evaluates SSRIs, Risk Of Suicidal Thoughts.
- Article from:
- BIOWORLD Today
- Article date:
- November 3, 2009
CopyrightCOPYRIGHT 2009 A Thomson Healthcare Company. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Washington Editor
BETHESDA, Md. - Some FDA regulators believe drug companies might need to conduct large, randomized, controlled studies to ascertain whether antidepressants prompt suicide or thoughts of suicide in kids. Such opinions were aired Monday before the FDA's psychopharmacologic and pediatric advisory panels concerning the use of selective serotonin reuptake inhibitors (SSRIs) in children.
Panel members heard analyses from the FDA and a committee of experts assembled by Columbia University to review trials involving kids with major depressive disorder (MDD) and other psychiatric disorders who might take products like Zoloft, Paxil or Prozac. ...